<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zakirova NF</submitter><funding>111 Project</funding><funding>The DevWeCan French Laboratories of Excellence Network</funding><funding>Russian Science Foundation</funding><funding>ANRS-MIE</funding><funding>DevWeCan French Laboratories of Excellence Network</funding><pagination>1036</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11201506</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(12)</volume><pubmed_abstract>Hepatitis C virus (HCV) is an oncogenic virus that causes chronic liver disease in more than 80% of patients. During the last decade, efficient direct-acting antivirals were introduced into clinical practice. However, clearance of the virus does not reduce the risk of end-stage liver diseases to the level observed in patients who have never been infected. So, investigation of HCV pathogenesis is still warranted. Virus-induced changes in cell metabolism contribute to the development of HCV-associated liver pathologies. Here, we studied the impact of the virus on the metabolism of polyamines and proline as well as on the urea cycle, which plays a crucial role in liver function. It was found that HCV strongly suppresses the expression of arginase, a key enzyme of the urea cycle, leading to th</pubmed_abstract><journal>Cells</journal><pubmed_title>Hepatitis C Virus Dysregulates Polyamine and Proline Metabolism and Perturbs the Urea Cycle.</pubmed_title><pmcid>PMC11201506</pmcid><funding_grant_id>B12003</funding_grant_id><funding_grant_id>ANR-10-LABX-61</funding_grant_id><funding_grant_id>22157</funding_grant_id><funding_grant_id>19-74-10086</funding_grant_id><pubmed_authors>Molle J</pubmed_authors><pubmed_authors>Valuev-Elliston VT</pubmed_authors><pubmed_authors>Smirnova OA</pubmed_authors><pubmed_authors>Ivanov AV</pubmed_authors><pubmed_authors>Zakirova NF</pubmed_authors><pubmed_authors>Bovet C</pubmed_authors><pubmed_authors>Grigorov B</pubmed_authors><pubmed_authors>Ivanova ON</pubmed_authors><pubmed_authors>Rindlisbacher B</pubmed_authors><pubmed_authors>Bartosch B</pubmed_authors><pubmed_authors>Karpenko IL</pubmed_authors><pubmed_authors>Khomutov AR</pubmed_authors><pubmed_authors>Monnier L</pubmed_authors><pubmed_authors>Yanvarev DV</pubmed_authors><pubmed_authors>Duponchel S</pubmed_authors><pubmed_authors>Khomich OA</pubmed_authors><pubmed_authors>Kochetkov SN</pubmed_authors><pubmed_authors>Golikov MV</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hepatitis C Virus Dysregulates Polyamine and Proline Metabolism and Perturbs the Urea Cycle.</name><description>Hepatitis C virus (HCV) is an oncogenic virus that causes chronic liver disease in more than 80% of patients. During the last decade, efficient direct-acting antivirals were introduced into clinical practice. However, clearance of the virus does not reduce the risk of end-stage liver diseases to the level observed in patients who have never been infected. So, investigation of HCV pathogenesis is still warranted. Virus-induced changes in cell metabolism contribute to the development of HCV-associated liver pathologies. Here, we studied the impact of the virus on the metabolism of polyamines and proline as well as on the urea cycle, which plays a crucial role in liver function. It was found that HCV strongly suppresses the expression of arginase, a key enzyme of the urea cycle, leading to th</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-04-08T19:06:29.629Z</modification><creation>2025-02-19T00:16:04.508Z</creation></dates><accession>S-EPMC11201506</accession><cross_references><pubmed>38920664</pubmed><doi>10.3390/cells13121036</doi></cross_references></HashMap>